Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.93 Million USD | 1377.04% |
| 2022 | 401.54 Thousand USD | -24.89% |
| 2021 | 534.59 Thousand USD | 6.93% |
| 2020 | 499.97 Thousand USD | 1899.9% |
| 2019 | 25 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 229.84 Thousand USD | -42.76% |
| 2023 FY | 5.93 Million USD | 1377.04% |
| 2023 Q4 | 5.93 Million USD | 3377.04% |
| 2023 Q3 | 170.57 Thousand USD | -14.9% |
| 2023 Q2 | 200.45 Thousand USD | -12.79% |
| 2022 Q3 | 444.63 Thousand USD | -7.7% |
| 2022 Q4 | 401.54 Thousand USD | -9.69% |
| 2022 FY | 401.54 Thousand USD | -24.89% |
| 2022 Q1 | 508.37 Thousand USD | -4.91% |
| 2022 Q2 | 481.71 Thousand USD | -5.24% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 534.59 Thousand USD | 6.93% |
| 2021 Q4 | 534.59 Thousand USD | 36.67% |
| 2021 Q3 | 391.16 Thousand USD | 0.0% |
| 2020 FY | 499.97 Thousand USD | 1899.9% |
| 2020 Q4 | 490.61 Thousand USD | 0.0% |
| 2019 FY | 25 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cosmos Health Inc. | 3.03 Million USD | -95.398% |
| Safety Shot Inc | 304.9 Thousand USD | -1845.184% |
| Bright Green Corporation | 201.78 Thousand USD | -2839.297% |
| Embecta Corp. | 1.62 Billion USD | 99.635% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 98.085% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 93.488% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 98.789% |
| Dynavax Technologies Corporation | 252.41 Million USD | 97.65% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 98.817% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | 55.493% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 98.846% |
| PainReform Ltd. | 30 Thousand USD | -19670.003% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1000.3% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1000.3% |
| SCYNEXIS, Inc. | 12.15 Million USD | 51.221% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -4963.649% |
| Journey Medical Corporation | 14.62 Million USD | 59.438% |
| Alpha Teknova, Inc. | 13.25 Million USD | 55.241% |
| Procaps Group, S.A. | 28.41 Million USD | 79.124% |
| Theratechnologies Inc. | 51.26 Million USD | 88.43% |
| Harrow Health, Inc. | 183.17 Million USD | 96.762% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -6717.243% |
| Biofrontera Inc. | 804 Thousand USD | -637.687% |
| DURECT Corporation | 2.7 Million USD | -119.504% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 82.133% |
| Cronos Group Inc. | 1.55 Million USD | -280.436% |
| OptiNose, Inc. | 611 Thousand USD | -870.704% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 98.81% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 82.653% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -1203.517% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 90.236% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 53.607% |
| Radius Health, Inc. | 339.66 Million USD | 98.254% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | 42.182% |
| Phibro Animal Health Corporation | 458.28 Million USD | 98.706% |
| Procaps Group S.A. | 28.41 Million USD | 79.124% |
| Alvotech | 1.02 Billion USD | 99.423% |
| TherapeuticsMD, Inc. | 6.53 Million USD | 9.201% |
| Viatris Inc. | 16.18 Billion USD | 99.963% |
| Rockwell Medical, Inc. | 8.29 Million USD | 28.482% |
| Aytu BioPharma, Inc. | 10.87 Million USD | 45.472% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -1665.226% |
| Tilray Brands, Inc. | 287.93 Million USD | 97.94% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 95.078% |
| Shineco, Inc. | 10.01 Million USD | 40.793% |
| PetIQ, Inc. | 437.82 Million USD | 98.645% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -2724.286% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 97.704% |
| Alimera Sciences, Inc. | 64.48 Million USD | 90.803% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | 84.6% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -4290.44% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | 13.509% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -723.75% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -26278.763% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 81.896% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 99.423% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 89.45% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 99.037% |
| Currenc Group, Inc. | 2.5 Million USD | -136.58% |
| Kamada Ltd. | 7.43 Million USD | 20.261% |
| Indivior PLC | 235.66 Million USD | 97.483% |
| Evoke Pharma, Inc. | 5 Million USD | -18.62% |
| Flora Growth Corp. | 942 Thousand USD | -529.618% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -26278.763% |
| Evolus, Inc. | 120.35 Million USD | 95.072% |
| HUTCHMED (China) Limited | 48.18 Million USD | 87.692% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 98.993% |
| Akanda Corp. | 2.49 Million USD | -137.51% |